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Osteoarthritis (OA); the most common form of degenerative joint disease; is asso-
ciated with variations in pro-inflammatory growth factor levels; inflammation and 
hypocellularity resulting from chondrocyte apoptosis (1). Pituitary adenylate cyclase-
activating polypeptide (PACAP) is a neuropeptide endowed with a range of trophic 
effects in several cell types; including chondrocytes (2). However; its role in OA has 
not been studied. To address this issue; we investigated whether PACAP expression 
is affected in OA cartilage obtained from experimentally-induced OA rat models; and 
then studied the effects of PACAP in isolated chondrocytes exposed to IL-1β in vitro 
to mimic the inflammatory milieu of OA cartilage. OA induction was established by 
histomorphometric and histochemical analyses. Changes in PACAP distribution in 
cartilage or its concentration in synovial fluid (SF) were assessed by immunohisto-
chemistry and ELISA. Results showed that PACAP abundance in cartilage tissue and 
SF was high in healthy controls. OA induction decreased PACAP levels both in affect-
ed cartilage and SF. In vitro; PACAP prevented IL-1β-induced chondrocyte apoptosis; 
as determined by MTT assay; Hoechst staining and western blots of apoptotic-relat-
ed proteins. These changes were also accompanied by decreased i-NOS and COX-2 
levels; suggesting an anti-inflammatory effect. Altogether, these findings support a 
potential role for PACAP as a chondroprotective agent for the treatment of OA.
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